Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

  • SCYNEXIS (NASDAQ:SCYX) shares increased by 11.1% to $4.5 during Wednesday's after-market session. The market value of their outstanding shares is at $107.7 million.
  • Clover Health Investments (NASDAQ:CLOV) stock rose 8.45% to $2.18. Today's trading volume for this security ended up closing at 1.7 million shares, which is 12.2 percent of its average volume over the last 100 days. The company's market cap stands at $1.0 billion. As per the news, the Q4 earnings report came out today.
  • Allena Pharmaceuticals (NASDAQ:ALNA) stock moved upwards by 6.93% to $0.41. The market value of their outstanding shares is at $35.0 million.
  • MannKind (NASDAQ:MNKD) shares increased by 6.01% to $3.88. The market value of their outstanding shares is at $974.8 million.
  • Cross Country Healthcare (NASDAQ:CCRN) shares increased by 5.95% to $22.25. The market value of their outstanding shares is at $845.5 million. As per the press release, Q4 earnings came out today.
  • Evolent Health (NYSE:EVH) shares increased by 5.8% to $23.5. The company's market cap stands at $2.1 billion. As per the news, the Q4 earnings report came out today.

Losers

  • Vanda Pharmaceuticals (NASDAQ:VNDA) shares fell 10.5% to $11.7 during Wednesday's after-market session. The market value of their outstanding shares is at $651.8 million. As per the press release, Q4 earnings came out today.
  • Privia Health Group (NASDAQ:PRVA) stock declined by 10.34% to $21.0. The market value of their outstanding shares is at $2.2 billion.
  • Xenetic Biosciences (NASDAQ:XBIO) shares fell 6.39% to $0.87. The company's market cap stands at $11.6 million.
  • Modular Medical (NASDAQ:MODD) stock declined by 5.41% to $2.8. The market value of their outstanding shares is at $24.8 million.
  • Theravance Biopharma (NASDAQ:TBPH) shares fell 4.83% to $8.67. The market value of their outstanding shares is at $638.9 million. The company's, Q4 earnings came out today.
  • Solid Biosciences (NASDAQ:SLDB) stock declined by 3.86% to $0.85. The market value of their outstanding shares is at $93.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.